Sn. Jowitt et al., CLONAL REMISSIONS IN ACUTE MYELOID-LEUKEMIA ARE COMMONLY ASSOCIATED WITH FEATURES OF TRILINEAGE MYELODYSPLASIA DURING REMISSION, British Journal of Haematology, 85(4), 1993, pp. 698-705
Clonal haemopoiesis has previously been demonstrated in some 30% of pa
tients in remission of acute myeloid leukaemia (AML). Whilst a 'clonal
remission' in many such patients may represent a skewed X-chromosome
inactivation pattern in haemopoietic cells, its relationship to an und
erlying preleukaemic state remains uncertain. We therefore analysed th
e clonal status of 48 female patients in remission of AML using X-chro
mosome linked restriction fragment length polymorphisms (RFLPs) within
the X-linked PGK and HPRT genes and the DXS255 (M27beta) locus, and c
arried out in conjunction a detailed study of the morphological and ka
ryotypic features of the patients' bone marrows. During remission, 35
patients (73%) with AML demonstrated non-clonal haemopoiesis, and thei
r bone marrows were morphologically normal. Remission haemopoietic tis
sue in nine cases (19%) showed a skewed X-chromosome inactivation patt
ern and remission bone marrows in these patients had features of trili
neage myelodysplasia (TMDS), with seven having similar features at pre
sentation. Analysis of constitutional DNA showed a non-clonal pattern
in seven of these patients, but was unsuccessful in two cases. These n
ine patients with post-chemotherapy TMDS were considered to have true
clonal haemopoiesis. Four patients (8%) with a skewed X-chromosome ina
ctivation pattern had normal remission bone marrows. Analysis of const
itutional DNA showed a skewed pattern in two of these patients, but wa
s unsuccessful in two cases. Cytogenetic investigation during remissio
n in the nine patients with TMDS showed a normal karyotype in four cas
es and the acquisition of new karyotypic abnormalities in three cases.
In contrast, 10 female patients in remission of de novo acute lymphob
lastic leukaemia (ALL) were shown to have non-clonal haemopoiesis. We
conclude that the majority of patients with AML who achieve remission
after cytoreductive chemotherapy have non-clonal haemopoiesis, and whe
n clonal remissions are observed these are commonly associated with th
e development of trilineage myelodysplasia in the bone marrow, with or
without karyotypic abnormalities. True clonal remission in associatio
n with morphologically normal haemopoiesis is a rare entity, the signi
ficance and frequency of which remain uncertain.